1

Shuttle Pharmaceuticals

Shuttle Pharmaceuticals
Leadership team

Joshua M. Schafer (Independent Director)

Steven Richards (Independent Director)

Milton Brown (Co-Founder, Chief Scientific Officer for Chemistry & Director)

Products/ Services
Biotechnology, Pharmaceutical, Therapeutics
Number of Employees
0 - 50
Headquarters
Rockville, Maryland, United States
Established
2012
Company Registration
SEC CIK number: 0001757499
Traded as
NASDAQ:SHPH
Overview
Location
Summary
Shuttle Pharmaceuticals is a leading provider of life-saving drugs, vaccines and treatments for a variety of conditions worldwide.
History

Since 1995, Shuttle Pharma has been providing high-quality, innovative products and services to healthcare institutions, consumers and business partners around the world. From its initial launch in Australia and Latin America, the company's product portfolio has expanded to include products for many regions across the globe.

Mission
Shuttle Pharma’s mission is to improve health outcomes for patients by providing life-saving products and services.
Vision
Shuttle Pharma’s vision is to be the world’s leading provider of life-saving drugs, vaccines and treatments.
Key Team

Anatoly Dritschilo (Co-Founder, MD, CEO & Chairman of the Board)

Christopher Senanayake (Independent Director)

Bette Jacobs (Independent Director)

Recognition and Awards
Shuttle Pharma has won numerous awards, including the 2019 ISPE International Quality Award and the 2018 World Pharma Innovation Award.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Shuttle Pharmaceuticals
Leadership team

Joshua M. Schafer (Independent Director)

Steven Richards (Independent Director)

Milton Brown (Co-Founder, Chief Scientific Officer for Chemistry & Director)

Products/ Services
Biotechnology, Pharmaceutical, Therapeutics
Number of Employees
0 - 50
Headquarters
Rockville, Maryland, United States
Established
2012
Company Registration
SEC CIK number: 0001757499
Traded as
NASDAQ:SHPH